According to the cut-off, low LGALS3BP expression (staining of ≤69% of the neoplastic cells) was detected in 151/196 (77%) CRC tumors, while high LGALS3BP expression was detected in 45/196 (23%). Here, LGALS3BP is linked to colorectal carcinoma.